Geum iranicum Khatamsaz, belonging to the Rosaceae family, is an endemic plant of Iran. The methanol extract of the roots of this plant showed signifi cant activity against one of the clinical isolates of Helicobacter pylori which was resistant to metronidazole. The aim of this study was the isolation and evaluation of the major compounds of G. iranicum effective against H. pylori. The compounds were isolated using various chromatographic methods and identifi ed by spectroscopic data ( 1 H and 13 C NMR, HMQC, HMBC, EI-MS). An antimicrobial susceptibility test was performed employing the disk diffusion method against clinical isolates of H. pylori and a micro dilution method against several Gram-positive and Gram-negative bacteria; additionally the inhibition zone diameters (IZD) and minimum inhibitory concentrations (MIC) values were recorded. Nine compounds were isolated: two triterpenoids, uvaol and niga-ichigoside F1, three sterols, β-sitosterol, β-sitosteryl acetate, and β-sitosteryl linoleate, one phenyl propanoid, eugenol, one phenolic glycoside, gein, one fl avanol, (+)-catechin, and sucrose. The aqueous fraction, obtained by partitioning the MeOH extract with water and chloroform, was the most effective fraction of the extract against all clinical isolates of H. pylori. Further investigation of the isolated compounds showed that eugenol was effective against H. pylori but gein, diglycosidic eugenol, did not exhibit any activity against H. pylori. The subfraction D 4 was the effective fraction which contained tannins. It appeared that tannins were probably the active compounds responsible for the anti-H. pylori activity of G. iranicum. The aqueous fraction showed a moderate inhibitory activity against both Gram-positive and Gram-negative bacteria. The MIC values indicated that Gram-positive bacteria including Staphylococcus aureus, Staphylococcus epidermidis, and Bacillus subtilis are more susceptible than Gram-neagative bacteria including Escherichia coli and Pseudomonas aeruginosa.
Introduction
Helicobacter pylori colonizes the stomachs of about 50% of the world's human population. This organism is the main risk factor for peptic ulceration as well as gastric mucosal-associated lymphoid tissue (MALT) lymphoma and gastric adenocarcinoma. The prevention of H. pylori colonization could potentially provide primary prevention of the mentioned diseases (Fauci et al., 2008) . The common treatments of H. pylori infection, including antibiotics and a proton pump inhibitor, may fail for several reasons. The main reason was found to be H. pylori resistance to antibiotics like clarithromycin and metronidazole (Mégraud, 2004) . Therefore, the research for new anti-H. pylori drugs from plant sources is ongoing (Nariman et al., 2004) .
The genus Geum, belonging to the Rosaceae family, is a perennial rhizomatous herb with fi ve species in Iran of which G. iranicum Khatamsaz is an endemic one (Khatamsaz, 1992; Mozaffarian, 1996). Some Geum species are used as medicinal plants in folk medicine (Vollmann and Schultze, 1995; Gruenwald, 2004) . The roots of G. urbanum and G. rivale are employed against diarrhea (Gruenwald, 2004) , and G. japonicum has been used as diuretic and astringent in traditional Chinese medicine and Japanese folk medicine . In an Iranian folk remedy, the infusion of the root of G. iranicum is employed to treat gastrointestinal disorders like diarrhea, and a decoction of the whole plant is combined with wheat fl our and used as a poultice for frostbite (Abutorabi, 2001) . Previous studies on extracts of Geum species have shown that they can be effective in the treatment of some diseases. A new triterpene acid, 2α,19α-dihydroxy-3-oxo-urs-12-en-28-oic acid, from the extract of G. japonicum showed potent inhibitory activity against HIV-1 protease . In addition, the extract of G. japonicum was active against HSV-1 and HSV-2 (herpes simplex virus) (Kurokawa et al., 1995) and CMV (cytomegalo virus) (Yukawa et al., 1996) . Some tannins isolated from the extract of this plant showed potent anticoagulant activity (Zeng et al., 1998) . Other Geum species showed antioxidant (Russo et al., 2005) , antimicrobial (Panizzi et al., 2000) , and anti-infl ammatory (Tunón et al., 1995) effects, respectively. In another study, antimicrobial activity was reported for the extract and essential oil of Geum kokanicum that was collected in Iran (Faramarzi et al., 2008) . Furthermore, the polar extract of this species showed a potent inhibitory effect on matrix metalloproteinase activity at minimal cytotoxic doses (Khorramizdeh et al., 2006) .
Anti-Helicobacter pylori Activity of the Methanolic Extract of Geum iranicum and its Main Compounds
A literature review revealed that the anti-H. pylori activity of Geum species has not been investigated. In the present study we aimed therefore to evaluate the activity of various extracts, sub-fractions, and main components of G. iranicum against clinical isolates of H. pylori (resistant to metronidazole). Furthermore, the evaluation of the antibacterial activity (against Gram-positive and Gram-negative bacteria) of fractions, together with the isolation and identifi cation of the separated compounds, is reported.
Material and Methods

General experimental procedures
Silica gel 60 F 254 pre-coated plates (Merck, Darmstadt, Germany) and anisaldehyde/H 2 SO 4 reagent followed by heating were used for detecting the compounds. NMR experiments were performed on a Bruker Avance 500 DRX (500 MHz for 1 H and 125 MHz for 13 C) spectrometer (Rheinstetten, Germany). EI-MS spectra were measured on an Agilent Technology (Palo Alto CA, USA) instrument with a 5973 Network mass selective detector (MS model). A CO 2 incubator (Heraeus, Hamburg, Germany) was used for the antibacterial susceptibility tests. 
Plant collection
Roots of
Antimicrobial susceptibility test
Three clinical isolates of H. pylori, Is.1, Is.2, and Is.3, were obtained from patients with chronic gastritis who had been referred to the Endoscopy Unit at Shariati Hospital, Tehran, Iran. Antral biopsies with positive rapid urease tests were cultured in the microbiology laboratory as described in our previous study (Siavoshi et al., 2010 ). Antimicrobial susceptibility was tested by the disk diffusion method according to the guidelines of the NCCLS (2006) . Serial dilutions of test samples were made in dimethyl sulfoxide (DMSO) (100, 50, 25, 12.5 μg/ml) . Bacterial suspensions were prepared in normal saline with the turbidity of McFarland standard No. 2 (equivalent to 6 · 10 8 cell/ml). The surface of blood agar plates was inoculated with 100 μl of each bacterial suspension. Then, plates were dried at room temperature for about 10 min. The sterile blank disks (6 mm in diameter) were placed on the surface of inoculated plates and impregnated with 10 μl of each sample dilution. Control plates included blank disks impregnated with 10 μl of DMSO. Plates were incubated at 37 °C under microaerobic conditions and examined after 3 -5 d. The inhibition zone diameters (IZD) were recorded.
Antibacterial activity of the aqueous fraction was also tested against several Gram-positive and Gram-negative bacteria including Staphylococcus aureus ATCC 6538, Staphylococcus epider-midis ATCC 12228, Bacillus subtilis ATCC 6633, Escherichia coli ATCC 8739, and Pseudomonas aeruginosa ATCC 9027 by a micro dilution method using 96 U-shaped wells plates (NCCLS, 2006) . A 200-μl aliquot of stock solutions of the fraction (128 mg/ml) and ciprofl oxacin (100 μg/ml) as a standard antibiotic compound in Mueller-Hinton broth (MHB) were transferred into the fi rst well in each row and serially diluted by mixing with 100 μl of MHB in subsequent wells. Then 100 μl of bacterial suspension (1 · 10 6 CFU/ml) were added to each well to reach the fi nal inoculum size of about 5 · 10 5 CFU/ml. After 24 h of incubation at 35 °C, the microdilution trays were tested for the absence or presence of visible growth. The endpoint minimum inhibitory concentration (MIC) is the lowest concentration of the fraction at which the test strain does not demonstrate visible growth.
Extraction and isolation procedure
Dried roots of G. iranicum (1 kg) were cut into small pieces and extracted with EtOAc and MeOH (3 × 4 l for each solvent), successively, by percolation at room temperature to obtain EtOAc (6 g) and MeOH (75 g) extracts. The EtOAc extract was subjected to silica gel column chromatography (CC) (4 × 20 cm) using n-hexane/CHCl 3 (7:3, 3:7 v/v), EtOAc, and MeOH as eluents to give 7 fractions (A -G). Fraction A was further separated by silica gel CC (3 × 20 cm) with n-hexane, n-hexane/CHCl 3 (7:3, 3:7 v/v) and CHCl 3 to give 5 fractions (A 1 -A 5 ) of which fraction A 3 contained compound 1 (15 mg). Silica gel CC (2 × 20 cm) was used for separation of fraction B to yield 7 fractions (B 1 -B 7 ) with n-hexane/CHCl 3 (7:3, 6:4, 4:6 v/v) and CHCl 3 . Fraction B 2 was 2 (22 mg). Fraction C was fractionated with n-hexane/CHCl 3 (9:1, 5:5 v/v) by silica gel CC (2 × 20 cm) to give fractions C 1 -C 5 ; compound 3 (141 mg) was isolated from fraction C 4 . Compound 4 (5 mg) was obtained from fraction D using silica gel CC (2.5 × 20 cm) with n-hexane/EtOAc (8:2 v/v).
The MeOH extract (75 g) was suspended in water and extracted with CHCl 3 to obtain CHCl 3 and aqueous fractions. The CHCl 3 fraction was further chromatographed with n-hexane/CHCl 3 (7:3, 3:7 v/v) and CHCl 3 to give 6 fractions of which fraction 5 was compound 5 (17 mg). The aqueous portion of the MeOH extract (70 g) was subjected to silica gel CC (10 × 20 cm) with EtOAc, EtOAc/ MeOH (9:1, 7:3, 4:6 v/v) and MeOH to yield 6 fractions (A -F). Fraction A was separated by silica gel CC (2.5 × 20 cm) with CHCl 3 /MeOH (19:1, 9:1, 8:2 v/v) to yield 5 fractions (A 1 -A 5 ). Fraction A 4 was compound 6 (129 mg). Fraction C was subjected to silica gel CC (2.5 × 20 cm) with CHCl 3 /MeOH (8:2, 7:3 v/v) to give 4 fractions (C 1 -C 4 ). Compound 7 (13 mg) was obtained from C 2 using silica gel CC (1.5 × 40 cm) with CHCl 3 / MeOH (75:25 v/v). Fraction D was chromatographed on a silica gel column (4 × 20 cm) with CHCl 3 /MeOH (8:2, 6:4 v/v) and MeOH to result in factions D 1 -D 4 of which D 2 was compound 8 (70 mg). Compound 9 (960 mg) was obtained from fraction E using silica gel CC (2.5 × 20 cm) with EtOAc/MeOH (6:4 v/v).
β-Sitosteryl acetate (1): R f = 0.14 in n-hexane/ CHCl 3 (7:3 v/v). -4', 5', 6', 7', 15', 16 ', 17'), 1.59 -1.65 (2H, m, H-3'), 2.03 -2.08 (4H, m, H-8', 14'), 2.29 (2H, t, J = 7.5 Hz, H-2'), 2.76 (2H, t, J = 6.5 Hz, H-11'), 4.6 (1H, m, H-3), 5.30 -5.40 (5H, m, olefi nic protons). (C-4) , 68.6 (C-3), 82.7 (C-2), 95.4 (C-8), 96.2 (C-6), 100.7 (C-10), 115.1 (C-2'), 116.0 (C-5'), 119.9 (C-6'), 132.0 (C-1'), 146.1 (C-3'), 146.1 (C-4'), 156.8 (C-9), 157.4 (C-5), 157.6 (C-7).
Niga-ichigoside F1 (2α,3β,19α,23-tetrahydroxyurs-12-en-28-oic acid β-D-glucopyranosyl ester) (7): R f = 0.47 in CHCl 3 /MeOH (75:25 v/v). Table I .
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Results
The inhibition zone diameters (IZD) of test samples and antibiotics against H. pylori are summarized in Tables II and III Table IV .
From the EtOAc and MeOH extracts of the roots, nine compounds including two triterpenoids, uvaol (4) (Mahato and Kundu, 1994) and niga-ichigoside F1 (7) (Bowen-Forbes et al., 2009) , three sterols, β-sitosterol (3), β-sitosteryl acetate (1) (Goad and Akihisa, 1997) , and β-sitosteryl linoleate (2) (Huh et al., 2010; Dyas et al., 1991) , one phenyl propanoid, eugenol (5), one phenolic glycoside, gein (8) (Takeda et al., 1998; Shimoda et al., 2007; Shigenaga et al., 1985) , one fl avanol, (+)-catechin (6) (Banavides et al., 2006) , and sucrose (9) (Agrawal, 1992) were isolated by column chromatography and identifi ed by comparison of their spectroscopic data with those in the literature (Fig. 1) . Spectroscopic data such as H COSY and EI-MS were employed for identifi cation of the isolated compounds. In the previous study, the NMR data of gein were reported in CDCl 3 and pyridine-d 5 (Shigenaga et al., 1985) . To the best of our knowledge, there is no report on the 2D-NMR correlations of this compound, so that this is the fi rst report on the NMR data of gein in CD 3 OD and HSQC and HMBC correlations (Table I and Fig. 2 ).
Discussion
The MeOH extract of G. iranicum was considered an effective extract against one of the clinical isolates of H. pylori which was resistant to metronidazole. As shown in Table II , the chloroform fraction, obtained from the MeOH extract, was not effective against H. pylori, but the aqueous fraction showed a potent activity (Table II) . Subfractions of the aqueous part were evaluated for their antibacterial activity against all isolates. Fraction D was the only one that displayed antibacterial activity (MIC = 25 μg/ml). Therefore, the fractions obtained from D fractionation were (Table II) . Finally, the isolated compounds from the chloroform and aqueous fractions (eugenol, gein, catechin, and niga-ichigoside F1) were examined for anti-H. pylori activity. Among the tested compounds, eugenol (5), isolated from the chloroform fraction, showed an antibacterial effect at a concentration of 100 μg/ml with inhibition zones of 20, 22, and 10 mm against the isolates 1, 2, and 3 respectively. Eugenol is a major compound in the root oil of G. iranicum (Shahani et al., 2011) and is employed as a fl avour- 
The results are shown as mean  SD (n = 3). b Is, clinical isolate of H. pylori.
ing agent in cosmetics and food products, as well as a cement material in dentistry (Atsumi et al., 2005) . Furthermore, eugenol has been found to exhibit a broad range of biological activities including antibacterial (Devi et al., 2010) , antifungal (Campaniello et al., 2010), antiviral (Benencia and Courreges, 2000) , antioxidant (Atsumi et al., 2005) , anti-infl ammatory (Yogalakshmi et al., 2010) , anti nociceptive (Daniel et al., 2009) , and antidepressant activity (Tao et al., 2005) . A literature review shows that the minimal bactericidal concentration (MBC) of eugenol (obtained from essential oils) was 100 μg/ml against one strain of H. pylori, which had been isolated from a pa- (Bergonzelli et al., 2003) . Elsewhere it was reported that eugenol (commercial preparation) inhibited the growth of 30 strains of H. pylori at a concentration of 2 μg/ ml (Ali et al., 2005) . Our antibacterial data for eugenol agree with the results reported by Bergonzelli et al. (2003) .
Diglycosylated eugenol, named gein (8), produced no inhibition zone. Gein has been isolated from other Geum species (Shigenaga et al., 1985) , and no biological activity has been reported for this compound. It seems that glycosylation of eugenol causes a decrease in anti-H. pylori activity. Also other purifi ed compounds like catechin (6) and niga-ichigoside F1 (7) did not display any antibacterial activity at all concentrations.
Fraction D 4 exhibited antibacterial activity as shown in Table II . Further investigation of fraction D 4 indicated that this fraction can precipitate a solution of gelatin (1%), containing sodium chloride (10%), and give a blue-black precipitate with ferric chloride. Therefore, this fraction should include polar compounds, especially hydrolysable tannins (Evans, 2009 ). There is a report in the literature on the antibacterial activity of hydrolysable tannins derived from medicinal plants against H. pylori (Funatogawa et al., 2004) . For this reason, it seems that tannins from G. iranicum might be one of the important groups of compounds active against H. pylori.
The aqueous fraction exhibited a moderate inhibitory activity against both Gram-positive and Gram-negative bacteria. The Gram-positive bacteria were inhibited at 16 mg/ml, while Gram-negative bacteria were inhibited at about 32 mg/ml.
In conclusion, considering the increasing resistance of H. pylori to antibiotics like metronidazole and clarithromycin, there is great interest in fi nding new drugs from natural sources. The results of this study show that G. iranicum has a signifi cant antibacterial activity against resistant clinical isolates of H. pylori. Eugenol is one of the effective compounds, whereas other purifi ed compounds (like gein, catechin, and niga-ichigoside F1) were not effective. Finally, the tannin-containing fraction of G. iranicum showed considerable anti-H. pylori activity. Further investigation is required to purify the active tannins from this plant.
